[Abstract] G protein-coupled receptors (GPCRs) promote cytoplasmic signalling by activating heterotrimeric G proteins in response to extracellular stimuli such as light, hormones and nucleosides.
9. Steritop 0.22 μm filter unit (EMD Millipore, catalog number: SCGPT01RE) 10. Amicon Ultra-15 concentrator 50 kDa cut-off (EMD Millipore, catalog number: UFC905024) 11 . Plastic column (e.g., empty PD-10 column) (GE Healthcare, catalog number: 17043501) 12 . PD-10 desalting column (GE Healthcare, catalog number: 17085101) 13. Amicon Ultra-4 concentrator 50 kDa cut-off (EMD Millipore, catalog number: UFC805024) 14. MRC 96-well 2-drop crystallization plates (Molecular Dimensions, catalog number: MD11-00-100) 15 . Ni 
Procedure

A. Expression of A2AR in insect cells
Human A2AR, which was truncated to remove the flexible C-terminus (see Note 1) and contained the N154A mutation to remove a potential N-linked glycosylation site, was cloned into the transfer vector pBacPAK8, and baculoviruses were prepared using the flashBAC ULTRA system, following the manufacturer's instructions. The A2AR construct contained a C-terminal 10x histidine tag to facilitate purification (see Note 2) and a TEV protease cleavage site to allow removal of the histidine tag ( Figure 1 ). transfer vector pBacPAK8 using BamHI and NotI restriction sites (underlined), and baculoviruses were prepared using the flashBAC ULTRA system. The construct consists of residues 1-308 of human A2AR followed by a TEV protease cleavage site (highlighted in green) and C-terminal 10x histidine tag (highlighted in red). A2AR contains the N154A mutation www.bio-protocol.org/e2234 
B. Insect cell membrane preparation
A crude membrane preparation is performed, which retains all insoluble intracellular components, whilst removing soluble proteins. This type of membrane preparation helps to limit the loss of membrane fragments and maximise the recovery of A2AR. This protocol describes the membrane preparation from three liters of insect cell culture, which is sufficient for one A2AR purification.
However, if necessary, two batches (six liters of culture in total) can be processed simultaneously using a single Ti45 ultracentrifuge rotor.
1. Thaw the cell pellet from 3 L of insect cell culture in a water bath at room temperature. 6 diffuse layer, resulting to a decreased yield of A2AR. Instead, the supernatant should be carefully aspirated using a serological pipette until level with the top of the membrane pellet (indicate by the dashed line).
4. Add 25 ml of buffer A to each tube and break the pellet up into small pieces using plastic spatula.
5. Homogenise the pellet using an ULTRA-TURRAX T25 homogeniser operating at 10,000 rpm until no lumps remain. This should take approximately 30 sec per tube.
6. Top up the tubes with buffer A and centrifuge at 158,000 x g (45,000 rpm) in a Ti45 rotor for 2 h at 4 °C. (see Note 3)
7. Remove the supernatant until level with the top of the pellet using a serological pipette (see Figure 2 ).
8. Resuspend the pellet with the buffer that remains in the tubes using a plastic spatula followed by an ULTRA-TURRAX T25 homogeniser. Do not exceed a final volume of 160 ml. Aliquot the membrane suspension into 50 ml tubes, flash freeze in liquid nitrogen and store at -80 °C.
Membranes can be stored under these conditions for up to three months.
C. Purification of A2AR
A2AR is purified in decylmaltoside (DM), in the presence of the agonist NECA, using a protocol adapted from a previously described method for the purification of a thermostabilised A2AR construct (Lebon et al., 2011a and 2011b; Tate and Lebon, 2015) . DM must be used if the complex is to be later exchanged into short chain detergents for vapour diffusion crystallisation. This protocol typically yields 3-6 mg of pure A2AR from 3 L of insect cell culture.
1. Thaw the membranes from 3 L of insect cell culture in a water bath at room temperature.
2. Add 4 protease inhibitor tablets, and NECA (100 μM), imidazole (10 mM), PMSF (1 mM), and NaCl (300 mM) to give the final concentrations indicated, stir slowly at room temperature for 30 min using a magnetic stirring bar to allow agonist binding. -NTA agarose resin (pre-equilibrated with buffer E) packed into a disposable plastic column and let it run through by gravity.
14. Collect the flow through and wash the column with 2 x 3 ml of buffer E.
15. Pool the wash with the flow through and concentrate to 0.2 ml using an Amicon Ultra-15
concentrator (50 kDa cut-off) in a refrigerated benchtop centrifuge at 4 °C.
16. Centrifuge the concentrated protein at 135,000 x g (55,000 rpm) in a TLA55 rotor using a benchtop ultracentrifuge for 10 min at 4 °C to remove aggregates. 2. Start the detergent exchange (from DM to OTG) by diluting the complex 1:10 in buffer F, and reconcentrating to 0.2 ml using an Amicon Ultra-4 concentrator (50 kDa cut-off) in a refrigerated benchtop centrifuge at 4 °C.
3. Centrifuge the concentrated protein at 135,000 x g (55,000 rpm) in a TLA55 rotor using a benchtop ultracentrifuge for 10 min at 4 °C to remove aggregates.
www.bio-protocol.org/e2234 gel filtration column (pre-equilibrated with buffer F) at a flow rate of 0.5 ml/min at 4 °C, collecting 0.5 ml fractions.
5. Pool peak fractions (typically 2-3 ml) based on the gel filtration chromatogram (Figure 3 ).
Figure 3. SDS-PAGE and gel filtration analysis of the A2AR purification. A and B. SDS-
PAGE analysis of the purification of a representative A2AR construct. Despite having molecular weights of 35 and 27 kDa respectively, A2AR and mini-Gs414 migrate at an identical rate on the SDS-PAGE gel, making visualisation of the complex difficult. Therefore, for demonstration purposes, we show SDS-PAGE gels of an A2AR construct that contains an N-terminal thioredoxin fusion (TrxA-A2AR), which increases its molecular weight to 46 kDa. TrxA-A2AR was purified in DM using an identical protocol to that described for A2AR, however, the TrxA-A2AR-mini-Gs complex, which was exchanged into OTG, did not yield crystals that diffracted to higher 6. Concentrate the pooled fractions to ≥ 20 mg/ml using an Amicon Ultra-4 concentrator (50 kDa cut-off) in a refrigerated benchtop centrifuge at 4 °C.
7. Centrifuge the concentrated protein at 55,000 rpm (135,000 x g) in a TLA55 rotor using a benchtop ultracentrifuge for 10 min at 4 °C to remove aggregates.
8. Transfer the supernatant to a new tube and discard the pellet.
9. Accurately determine the concentration of the complex using the amido black assay (Schaffner and Weissmann, 1973) . 
Data analysis
Chromatograms were visualised using UNICORN software and graphs were plotted using GraphPad Prism 7. Statistical analysis was not required for this work.
Notes
1. The A2AR construct described here contains a deletion to remove the flexible C-terminus, the length of this deletion was one area of optimisation used to improve the diffraction of the A2AR-mini-Gs crystals. Crystallisation trials of the A2AR-mini-Gs complex were performed using A2AR
constructs that consisted of residues 1-308, 1-311 or 1-317. The best diffraction was observed using the construct consisting of residues 1-308 of A2AR. The A2AR-mini-Gs structure revealed that the C-terminal region of A2AR is involved in crystal contacts, which explains why A2AR constructs of different lengths affected the crystallisation of the complex.
2. A C-terminal 10x histidine tag and TEV protease cleavage site were utilised because this strategy has previously been used by our lab to purify and crystallise a thermostabilised A2AR
www.bio-protocol.org/e2234 5. It is important to use a refrigerated centrifuge when concentrating A2AR to maintain the temperature at a constant 4 °C. A non-refrigerated centrifuge located in a cold room will rapidly warm up during operation, which will result in the denaturation of the temperature-sensitive receptor.
6. Following buffer exchange, and during the overnight incubation with TEV protease, a white precipitate may be observed. The composition of this precipitate is unknown, but it does not contain a significant amount of A2AR and can be removed by centrifugation at 5,000 x g for 5 min at 4 °C prior to the Ni 2+ -NTA negative purification step.
7. A2AR usually elutes from the preparative gel filtration column as a broad asymmetric peak of 3-4 ml in volume. The reason for this is unknown, but it may be due to excess detergent, carried over from the solubilisation and purification, affecting the migration of A2AR through the gel filtration matrix. After pooling and concentrating the peak fractions from the preparative gel filtration run, a small analytical sample of A2AR (~100 μg) can be re-run on the same column.
This sample should resolve as a sharp peak and is a better indicator of the quality of the purified receptor than the preparative gel filtration profile.
8. The amido black assay (Schaffner and Weissmann, 1973 ) is one of the most reliable ways to accurately determine the concentration of membrane proteins in the presence of detergent and ligand.
9. A2AR that has been frozen and thawed retains its ability to form a complex with mini-Gs and this complex can be crystallised with similar results to those observed when using freshly prepared receptor. Buffer E contains 10% glycerol, so additional cryoprotectants are not required.
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. The shortest incubation time tested was three hours, after which the A2AR-mini-Gs complex was fully formed. However, an overnight incubation does not negatively affect the stability of the complex and is often more convenient.
11. Membrane protein samples should never be boiled before loading on SDS-PAGE because this causes the protein to aggregate.
12. Crystallisation plates must be set up and incubated at 4 °C, even short-term exposure to elevated temperatures will result in denaturation of the complex.
13. Cryoprotection using 30% PEG 400 resulted in visible shrinkage of the crystals. The extent of this dehydration varied between crystals, meaning that datasets collected from different crystals www.bio-protocol.org/e2234 
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were difficult to merge. Increasing the concentration of the cryoprotectant in a stepwise manner resulted in more uniform dehydration of the crystals, and allowed the collection of diffraction data that could be reliably merged.
14. PMSF solutions must be prepared in an anhydrous solvent (such as absolute ethanol), because even a small water content will cause rapid hydrolysis of the PMSF rendering it inactive. PMSF stock solutions prepared in absolute ethanol are stable and can be conveniently stored at 4 °C for several months. Note that the PMSF solution should be warmed to room temperature before opening to prevent condensation entering the solvent.
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